Precision BioSciences Inc has a consensus price target of $16 based on the ratings of 21 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Guggenheim on May 30, 2024, May 16, 2024, and April 30, 2024, respectively. With an average price target of $46.33 between HC Wainwright & Co., HC Wainwright & Co., and Guggenheim, there's an implied 392.91% upside for Precision BioSciences Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/30/2024 | Buy Now | 538.3% | HC Wainwright & Co. | Patrick Trucchio | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
05/16/2024 | Buy Now | 538.3% | HC Wainwright & Co. | Patrick Trucchio | → $60 | Reiterates | Buy → Buy | Get Alert |
04/30/2024 | Buy Now | 102.13% | Guggenheim | Debjit Chattopadhyay | → $19 | Initiates | → Buy | Get Alert |
04/17/2024 | Buy Now | 538.3% | HC Wainwright & Co. | Patrick Trucchio | → $60 | Reiterates | Buy → Buy | Get Alert |
03/28/2024 | Buy Now | 538.3% | HC Wainwright & Co. | Patrick Trucchio | $3 → $60 | Maintains | Buy | Get Alert |
02/14/2024 | Buy Now | -68.09% | HC Wainwright & Co. | Patrick Trucchio | → $3 | Reiterates | Buy → Buy | Get Alert |
09/19/2023 | Buy Now | -68.09% | HC Wainwright & Co. | Patrick Trucchio | → $90 | Reiterates | Buy → Buy | Get Alert |
08/17/2023 | Buy Now | -68.09% | HC Wainwright & Co. | Patrick Trucchio | $150 → $90 | Maintains | Buy | Get Alert |
08/07/2023 | Buy Now | — | HC Wainwright & Co. | Patrick Trucchio | — | Reiterates | → Buy | Get Alert |
07/28/2023 | Buy Now | -78.72% | BTIG | Thomas Shrader | $180 → $60 | Maintains | Buy | Get Alert |
07/28/2023 | Buy Now | -46.81% | HC Wainwright & Co. | Patrick Trucchio | $510 → $150 | Reiterates | Buy → Buy | Get Alert |
06/01/2023 | Buy Now | 80.85% | HC Wainwright & Co. | Patrick Trucchio | → $510 | Reiterates | Buy → Buy | Get Alert |
03/15/2023 | Buy Now | 80.85% | HC Wainwright & Co. | Patrick Trucchio | → $510 | Reiterates | → Buy | Get Alert |
03/14/2023 | Buy Now | -57.45% | BMO Capital | Kostas Biliouris | $210 → $120 | Downgrade | Outperform → Market Perform | Get Alert |
11/10/2022 | Buy Now | -89.36% | Goldman Sachs | Salveen Richter | $60 → $30 | Maintains | Neutral | Get Alert |
11/10/2022 | Buy Now | 80.85% | HC Wainwright & Co. | Patrick Trucchio | $600 → $510 | Maintains | Buy | Get Alert |
08/09/2022 | Buy Now | -78.72% | Goldman Sachs | Salveen Richter | $90 → $60 | Maintains | Neutral | Get Alert |
06/17/2022 | Buy Now | -25.53% | BMO Capital | Kostas Biliouris | → $210 | Initiates | → Outperform | Get Alert |
06/09/2022 | Buy Now | — | William Blair | Raju Prasad | — | Downgrade | Outperform → Market Perform | Get Alert |
03/16/2022 | Buy Now | -46.81% | Goldman Sachs | Salveen Richter | $360 → $150 | Maintains | Neutral | Get Alert |
09/10/2021 | Buy Now | 176.6% | Stifel | Benjamin Burnett | $690 → $780 | Maintains | Buy | Get Alert |
The latest price target for Precision BioSciences (NASDAQ:DTIL) was reported by HC Wainwright & Co. on May 30, 2024. The analyst firm set a price target for $60.00 expecting DTIL to rise to within 12 months (a possible 538.30% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for Precision BioSciences (NASDAQ:DTIL) was provided by HC Wainwright & Co., and Precision BioSciences reiterated their buy rating.
There is no last upgrade for Precision BioSciences
The last downgrade for Precision BioSciences Inc happened on March 14, 2023 when BMO Capital changed their price target from $7 to $4 for Precision BioSciences Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Precision BioSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Precision BioSciences was filed on May 30, 2024 so you should expect the next rating to be made available sometime around May 30, 2025.
While ratings are subjective and will change, the latest Precision BioSciences (DTIL) rating was a reiterated with a price target of $60.00 to $60.00. The current price Precision BioSciences (DTIL) is trading at is $9.40, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.